Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Price drop
View:
Post by CMHarring218431 on Oct 18, 2023 3:52pm

Price drop

My gut feeling which means nothing, is that the MM's are indeed walking it down in anticipation of good news. Lot of buys in the mix here. They make money on the way down and again on the way back up. Just ordinary market maneuvering. Wondering what the volume and direction will be tomorrow PM .Good Luck All
Comment by Cblifeforms on Oct 19, 2023 4:11am
Same feeling... No sense this price drop. Science is there. Cash is there. Clinical good results are there... IMHO someone accumulating while leading price down ? Not so difficult having cash & shares...
Comment by Lesalpes29 on Oct 19, 2023 7:12am
Don't know for sure but ... maybe Matt with his miss on deal date! for PanCan is not helping. Now Esmo, could be a game changer with very good NR. GL
Comment by fox7mf on Oct 19, 2023 8:52am
ESMO is NOT going to be a game changer, just as ASCO was all but ignored. The answer for the SP drop is that investors are getting tired of waiting for news on an acquisition by or partnership with a MAJOR!!!! THAT'S IT!!! THATS ALL!!! The market is blass about a relationship with a not for profit. They want to hear about Roche or Merck or any BP.
Comment by Azzak34 on Oct 19, 2023 9:02am
This man has all the answers ladies and gents. When we're scolded for speculation by those who consistently do it themselves, we've nearing peak stupidity. 
Comment by 13X2413 on Oct 19, 2023 9:14am
Speaking of stupidity, more cheapies available this morning. Who's going to step up?
Comment by Azzak34 on Oct 19, 2023 9:16am
You're not? 
Comment by fox7mf on Oct 19, 2023 9:25am
And while we wait for ESMO, and what promises to be outstanding data, there's a chance it will be revealed that Oncy's one CR is now a PR. Those not as well versed in the overall science as we are may take negative note of that. We need answers. Coffey is doing us a disservice BD wise. We can't always cheerlead, and must take off the rose colored glasses on occasion. 
Comment by Lesalpes29 on Oct 19, 2023 9:36am
Well said Fox... Matt look stupid with his empty calls! At least we have money to pay him!
Comment by Lesalpes29 on Oct 19, 2023 9:41am
If I'm not wrong the big participant of the last PP is probably down a couple of millions $$$! Lol
Comment by Journeytc on Oct 19, 2023 9:40am
Cannt believe the board didn't punt Matt after breast cancer trial travesty.  The board is useless.  ONC hired a chief medical officer who prepared a phase 3 filing about 5 years ago.  They were ready to go.   The chief medical officer resigned after ONC decided to hold off and do the AWARE study.   The breast cancer ICI combo failed, and it appears ...more  
Comment by ONCInvestor on Oct 19, 2023 9:56am
That is my guess, as well. I emailed IR on this point and received a very cryptic reply. I have followed up for more information. 
Comment by jh1970 on Oct 19, 2023 10:11am
Can you share with us this email ?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities